Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis

Clinical and Experimental Immunology

Volumn 105, Issue 3, 1996, Pages 523-528

  Ajjan, R A ^a   Watson, P F ^a   Mcintosh, R S ^a   Weetman, A P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Cytokines; Hashimoto's thyroiditis; Intrathyroidal lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; MESSENGER RNA;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CASE REPORT; DIAGNOSIS; ETIOLOGY; GENE EXPRESSION; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029843836     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-784.x     Document Type: Article

References (38)

1. Del Prete GF, Vercelli D, Tiri A et al. In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis. Clin Exp Immunol 1987; 65:643-6.
2. Del Prete GF, Tiri A, De Carli M et al. High potential to tumour necrosis factor-α production of thyroid infiltrating lymphocytes in Hashimoto's thyroiditis: a peculiar feature of thyroid autoimmunity. Autoimmunity 1989; 4:267-76.
3. Todd I, Pujol-Borrell R, Hammond LJ, Botazzo GF, Feldmann M. Interferon-γ induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 1985; 11:265-73.
4. Weetman AP, Borysicwicz LK. Regulation of major histocompatibility complex class II antigen expression by the FRTL-5 rat thyroid cell line. J Endocrinol 1987; 115:481-7.
5. Weetman AP, Rees AJ. Synergistic effects of recombinant tumour necrosis factor-α (TNF) and γ-interferon (γ-IFN) on rat thyroidal cell growth and Ia antigen expression. Immunology 1988; 63:285-9.
6. Weetman AP, Cohen SB, Makgoba MW, Borysiewicz LK. Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells. J Endocrinol 1989; 122:185-91.
7. Tandon N, Makgoba MW, Gahmberg CG, Weetman AP. The expression and role in T cell adhesion of LFA-3 and ICAM-2 on human thyroid cells. Clin Immunol Immunopathol 1992; 64:30-35.
8. Vargas F, Tolosa E, Sospedra M et al. Characterization of neural cell adhesion molecule (NCAM) expression in thyroid follicular cells: induction by cytokines and over-expression in autoimmune glands. Clin Exp Immunol 1994; 98:478-88.
9. Sato K, Sato HT, Shizume K et al. Inhibition of 125-I organification and thyroid hormone release by interleukin-1, tumour necrosis factor-alpha and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab 1990; 70:1745-3.
10. Tominaga T, Yamashita S, Nagayama Y et al. Interleukin-6 inhibits human thyroid peroxidase gene expression. Acta Endocrinol 1991; 124:290-6.
11. Huber GK, Davies TF. Human fetal thyroid cell growth in vitro: system characterization and cytokine inhibition. Endocrinol 1990; 126:869-75.
12. Rasmussen AK, Kayser L, Rasmussen UF, Bendtzen K. Influence of tumour necrosis factor-β and interferon-γ, separately and added together with interleukin-1β, on the function of cultured human thyroid cells. J Endocrinol 1994; 143:359-65.
13. Pang XP, Yoshimura M, Hershman JM. Suppression of rat thyrotroph and thyroid cell function by tumour necrosis factor-α. Thyroid 1993; 3:325-30.
14. Tandon N, Morgan BP, Weetman AP. Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells. Immunol 1992; 75:372-7.
15. Grubeck-Loebenstein B, Buchan G, Chantry D et al. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1α and interleukin-6. Clin Exp Immunol 1989; 77:324-30.
16. Watson PF, Pickerill AP, Davies R, Weetman AP. Semi-quantitative analysis of interleukin-1α, interleukin-6 and interleukin-8 mRNA expression by human thyrocyles. J Mol Endocrinol 1995; 15:11-21.
17. Zheng RQH, Abney ER, Chu CQ et al. Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells. Immunology 1992; 75:456-62.
18. Paschke R, Schuppert F, Taton M, Velu T. Intrathyroidal cytokine gene expression profiles in autoimmune thyroiditis. J Endocrinol 1994; 141:309-15.
19. Weetman AP, Volkman DJ, Burman KD, Gerrard TJ, Fauci AS. The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endocrinol Metab 1985; 61:817-24.
20. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86:9717-21.
21. Brenner CA, Tam AW, Nelson PA et al. Message amplification phenotyping (mapping) - a technique to simultaneously measure multiple messenger-RNAs from small numbers of cells. Biotechniques 1989; 7:1096-103.
22. Watson PF, Pickerill AP, Davies R, Weetman AP. Analysis of cytokine gene expression in Graves' disease and multinodular goiter. J Clin Endocrinol Metab 1994; 79:355-60.
23. McLachlan SM, Prummel MF, Rapoport B. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab 1994; 78:1070-4.
24. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77:1627-52.
25. Yamamoto JK, Farrar WL, Johnson HM. Interleukin-2 augments natural killer cell activity. Nature 1982; 291:335-8.
26. Migita K, Eguchi K, Tezuka H et al. Cytotoxic activity of interleukin-2 (IL-2) activated killer cells toward thyroid epithelial cells. Clin Exp Immunol 1989; 77:196-201.
27. Sato K, Yamazaki K, Shizume K et al. Pathogenesis of autoimmune hypothyroidism induced by lymphokine-activated killer (LAK) cell therapy: in vitro inhibition of human thyroid function by interleukin-2 in the presence of autologous intrathyroidal lymphocytes. Thyroid 1993; 3:179-88.
28. Mariotti S, Del Prete GF, Chiovato L et al. Cytokines and thyroid autoimmunity. Int J Immunopathol Pharmacol 1992; 5:103-13.
29. Hirano T. The biology of IL-6. Chem Immunol 1992; 51:153-80.
30. Weetman AP, Bright-Thomas R, Freeman M. Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 1990; 127:357-61.
31. Matsushima K, Morishita K, Yoshimura T et al. Neutrophil chemotactic factor (MDNCF) and the induction of MDNCF by interleukin 1 and tumour necrosis factor. J Exp Med 1988; 167:1883-93.
32. Larson CG, Anderson AO, Apella E. Oppenheim JJ, Matsushima K. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243:1464-6.
33. Grubeck-Loebestein B, Derfler K, Kassal H et al. Immunological features of nonimmunogenic hyperthyroidism. J Clin Endocrinol Metab 1985; 60:150-5.
34. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type I helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
35. Howard M, O'Garra A, Ishida H, de Waal Malefyt R, de Vries J. Biological properties of interleukin-10. J Clin Immunol 1992; 12:239-48.
36. Taverne J, Rayner DC, Van Der Meide PH, Lydyard PM, Bidey SP, Cooke A. Effects of tumour necrosis factor and interferon-gamma on thyroid cells. Eur J Immunol 1987; 17:1855-8.
37. Paschke R, Kist A, Jännicke R, Eck T, Velu T, Usadel KH. Lack of intrathyroidal tumour necrosis factor alpha in Graves' disease. J Clin Endocrinol Metab 1993; 76:97-102.
38. Sospedra M, Obiols G, Santamaria Babi LF et al. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect? J Immunol 1995; 154:4213-22.